Growth Metrics

Item 9 Labs (INLB) Change in Accured Expenses (2018 - 2023)

Item 9 Labs' Change in Accured Expenses history spans 12 years, with the latest figure at -$137595.0 for Q2 2023.

  • For Q2 2023, Change in Accured Expenses fell 142.68% year-over-year to -$137595.0; the TTM value through Jun 2023 reached $1.8 million, up 157.96%, while the annual FY2022 figure was $1.6 million, 167.32% up from the prior year.
  • Change in Accured Expenses reached -$137595.0 in Q2 2023 per INLB's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.7 million in Q3 2022 to a low of -$1.0 million in Q3 2020.
  • Average Change in Accured Expenses over 5 years is $164256.9, with a median of $172502.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 40713.66% in 2019, then crashed 261.51% in 2020.
  • A 5-year view of Change in Accured Expenses shows it stood at $335875.0 in 2019, then decreased by 19.56% to $270191.0 in 2020, then plummeted by 210.53% to -$298647.0 in 2021, then soared by 663.85% to $1.7 million in 2022, then tumbled by 108.17% to -$137595.0 in 2023.
  • Per Business Quant, the three most recent readings for INLB's Change in Accured Expenses are -$137595.0 (Q2 2023), $1.7 million (Q3 2022), and $322413.0 (Q2 2022).